Railway Pension Investments Ltd trimmed its position in shares of McKesson Corporation (NYSE:MCK – Free Report) by 1.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 107,642 shares of the company’s stock after selling 2,040 shares during the quarter. Railway Pension Investments Ltd’s holdings in McKesson were worth $81,334,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in MCK. University of Texas Texas AM Investment Management Co. acquired a new stake in McKesson during the 4th quarter worth approximately $25,000. Swiss RE Ltd. acquired a new position in shares of McKesson during the fourth quarter worth $26,000. Delos Wealth Advisors LLC acquired a new position in shares of McKesson during the second quarter worth $27,000. State of Wyoming bought a new stake in shares of McKesson in the second quarter worth $29,000. Finally, Kingdom Financial Group LLC. acquired a new stake in McKesson in the fourth quarter valued at $33,000. Institutional investors and hedge funds own 85.07% of the company’s stock.
McKesson Trading Down 0.9%
NYSE:MCK opened at $885.36 on Tuesday. McKesson Corporation has a 12 month low of $679.65 and a 12 month high of $999.00. The firm’s 50 day moving average is $836.11 and its 200 day moving average is $842.95. The stock has a market capitalization of $103.22 billion, a PE ratio of 23.69, a price-to-earnings-growth ratio of 1.76 and a beta of 0.30.
McKesson Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Tuesday, September 1st will be issued a $0.94 dividend. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Tuesday, September 1st. This is a positive change from McKesson’s previous quarterly dividend of $0.82. McKesson’s dividend payout ratio (DPR) is presently 8.78%.
Analyst Ratings Changes
Several equities research analysts recently commented on MCK shares. Citigroup upped their target price on McKesson from $945.00 to $1,000.00 and gave the company a “buy” rating in a research report on Friday, July 24th. Wall Street Zen cut shares of McKesson from a “buy” rating to a “hold” rating in a research report on Saturday, June 27th. Royal Bank Of Canada assumed coverage on shares of McKesson in a research note on Wednesday, August 19th. They issued a “sector perform” rating and a $845.00 target price for the company. UBS Group increased their price target on McKesson from $1,050.00 to $1,080.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Finally, Wells Fargo & Company boosted their price objective on McKesson from $812.00 to $933.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 11th. Fourteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $973.44.
View Our Latest Stock Analysis on MCK
Insiders Place Their Bets
In related news, CEO Brian S. Tyler sold 8,463 shares of the business’s stock in a transaction dated Tuesday, July 7th. The shares were sold at an average price of $793.56, for a total transaction of $6,715,898.28. Following the transaction, the chief executive officer owned 5,919 shares in the company, valued at $4,697,081.64. The trade was a 58.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley E. Lerman sold 301 shares of McKesson stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $892.33, for a total value of $268,591.33. The SEC filing for this sale provides additional information. Insiders have sold a total of 22,289 shares of company stock valued at $17,406,854 in the last quarter. Insiders own 0.06% of the company’s stock.
McKesson Company Profile
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Featured Stories
- Five stocks we like better than McKesson
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
